228 filings
Page 2 of 12
8-K
hiu35lhp
4 Jan 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:04pm
8-K
fn2 03ycj
9 Nov 22
Lexicon Pharmaceuticals Reports Third Quarter 2022
4:05pm
8-K
jb450lk1x7ga5rd 893
2 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
x276a dudd0s854t
2 Aug 22
Lexicon Pharmaceuticals Reports Second Quarter 2022
4:07pm
8-K
u03bu5z
29 Jul 22
Lexicon Announces Proposed Public Offering of Common Stock
5:18pm
8-K
tde7eou any
30 Jun 22
Lexicon Announces Positive Top-line Results from Phase 2 Proof-of-concept Study of LX9211 In Painful Diabetic Neuropathy
12:52pm
8-K
ty74g0ill44v0hjhd8b
25 May 22
Material Modifications to Rights of Security Holders
8:27am
8-K
7gf1 mo63s
5 May 22
Lexicon Pharmaceuticals Reports First Quarter 2022
6:10am
8-K
qf09025mzxqbidc7uj2
17 Mar 22
Entry into a Material Definitive Agreement
4:17pm
8-K
456fz
28 Feb 22
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-year 2021 Financial Results and Provides Clinical Update
6:17am
8-K
lc74uz4l2 s4
3 Nov 21
Lexicon Pharmaceuticals Reports Third Quarter 2021
4:05pm
8-K
yqf0p6fuv3qdn2bx
9 Sep 21
Departure of Directors or Certain Officers
4:10pm
8-K
mu06u5j6n
2 Aug 21
Departure of Directors or Certain Officers
7:23am
8-K
d6u zs3ukc
2 Aug 21
Lexicon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical Update
7:20am
8-K
d92j wksk
30 Jul 21
Results of Operations and Financial Condition
7:52am
8-K
gz3by6nbbc
30 Jul 21
Departure of Directors or Certain Officers
7:12am
8-K
kix2 ach3
6 May 21
Lexicon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical Update
4:11pm
8-K
jyyi ferf8z
3 May 21
Entry into a Material Definitive Agreement
4:08pm
8-K
mk6wmi79
1 Apr 21
Departure of Directors or Certain Officers
4:36pm
8-K
8gyqb6stvqtutmmiw4ng
10 Mar 21
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-year 2020 Financial Results and Provides Clinical Update
4:12pm